Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
701 (USA) · Dr. Reyes
consented 2012-07-22
Adverse events
Mild APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-05 (study day 137.0); relationship: PROBABLE
Mild APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-05 (study day 137.0); relationship: PROBABLE
Mild APPLICATION SITE IRRITATION — outcome: RECOVERED/RESOLVED; onset 2012-12-05 (study day 137.0); relationship: PROBABLE
Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-05 (study day 137.0); relationship: PROBABLE
Moderate COUGH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2010-06; relationship: NONE
Mild COUGH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2010-06; relationship: NONE
Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-08-07 (study day 17.0); relationship: NONE
Mild ERYTHEMA — outcome: RECOVERED/RESOLVED; onset 2012-08-07 (study day 17.0); relationship: NONE
Moderate MUSCULAR WEAKNESS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-07 (study day 48.0); relationship: NONE
Moderate MUSCULAR WEAKNESS — outcome: RECOVERED/RESOLVED; onset 2012-09-07 (study day 48.0); relationship: NONE
Mild NASAL MUCOSA BIOPSY — outcome: RECOVERED/RESOLVED; onset 2012-08-03 (study day 13.0); relationship: NONE
Moderate PNEUMONIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-07 (study day 48.0); relationship: NONE; serious criteria: hospitalization
Moderate PNEUMONIA — outcome: RECOVERED/RESOLVED; onset 2012-09-07 (study day 48.0); relationship: NONE; serious criteria: hospitalization
Mild SECRETION DISCHARGE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-08-07 (study day 17.0); relationship: NONE
Mild SECRETION DISCHARGE — outcome: RECOVERED/RESOLVED; onset 2012-08-07 (study day 17.0); relationship: NONE
Data queries
No data queries.